Tower Research Capital LLC (TRC) - WEREWOLF THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,029
-41.7%
2,350
-16.9%
0.00%
Q2 2023$8,622
+215450.0%
2,827
+85.5%
0.00%
Q1 2023$4
-73.3%
1,524
-78.7%
0.00%
-100.0%
Q4 2022$15
-100.0%
7,146
+9.4%
0.00%
Q3 2022$30,000
+200.0%
6,531
+178.7%
0.00%
Q2 2022$10,000
-16.7%
2,343
-13.8%
0.00%
Q1 2022$12,000
+50.0%
2,717
+316.7%
0.00%
Q4 2021$8,000
+14.3%
652
+56.0%
0.00%
Q3 2021$7,000
+600.0%
418
+703.8%
0.00%
Q2 2021$1,000520.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DC Funds, LP 589,102$1,260,67825.95%
MPM ASSET MANAGEMENT LLC 4,284,172$9,168,1284.91%
MPM BioImpact LLC 2,388,011$5,110,3441.36%
RA Capital Management 6,144,881$13,150,0450.26%
PFM Health Sciences, LP 2,558,282$5,474,7230.26%
SPHERA FUNDS MANAGEMENT LTD. 626,810$1,341,3730.24%
Rubric Capital Management LP 1,935,357$4,141,6640.16%
Laurion Capital Management LP 522,900$1,119,0060.01%
Alyeska Investment Group, L.P. 397,808$851,3090.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,511$204,3940.01%
View complete list of WEREWOLF THERAPEUTICS INC shareholders